Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine (CDA) in Patients With Hairy Cell Leukemia.
Phase of Trial: Phase III
Latest Information Update: 14 May 2012
At a glance
- Drugs Cladribine (Primary)
- Indications Hairy cell leukaemia
- Focus Adverse reactions
- 30 Mar 2012 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 07 Sep 2005 New trial record.